Horizon Pharma plc Withdraws Offer to Acquire Depomed, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Jefferies Reinstates Horizon Pharma (HZNP) at Buy
November 23, 2015 7:39 AM ESTJefferies reinstates coverage on Horizon Pharma (NASDAQ: HZNP) with a Buy rating and a price target of $32.00 (from $37.00), saying standalone growth appears healthy and near-term M&A is likely.
Analyst David Steinberg commented, "HZNP abandoned its hostile takeover attempt of DEPO following... More
Depomed (DEPO) Issues Commentary on Horizon Pharma's (HZNP) Revoked Acquisition Proposal
November 20, 2015 6:57 AM ESTDepomed (Nasdaq: DEPO) issued the following statement regarding Horizon Pharma plc's (Nadaq: HZNP) decision to withdraw its... More
Horizon Pharma (HZNP) Withdraws Offer to Acquire Depomed (DEPO)
November 19, 2015 8:18 PM ESTHorizon Pharma (Nasdaq: HZNP) announced that at a hearing held today, Judge Peter Kirwan of the Superior Court of California for the County of Santa Clara granted Depomed Inc.'s (Nasdaq: DEPO) motion for preliminary injunctive relief against Horizon Pharma's alleged use of... More
